BioNTech SE (22UA) Financial Statements

1 Followers

BioNTech SE Financial Overview

BioNTech SE's market cap is currently CHF21.07B. The company's EPS TTM is CHF-6.73; its P/E ratio is -13.25; BioNTech SE is scheduled to report earnings on August 4, 2026, and the estimated EPS forecast is CHF0.69. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	€ 2.76B	€ 2.75B	€ 3.82B	€ 17.31B	€ 18.98B
Gross Profit	€ 2.14B	€ 2.21B	€ 3.22B	€ 14.32B	€ 16.07B
Operating Income	€ -623.87M	€ -1.31B	€ 690.40M	€ 12.64B	€ 15.28B
EBITDA	€ -628.00M	€ -367.10M	€ 1.38B	€ 13.10B	€ 15.00B
Net Income	€ -1.09B	€ -665.30M	€ 930.30M	€ 9.43B	€ 10.29B
Balance Sheet
Cash & Short-Term Investments	€ 14.83B	€ 16.78B	€ 16.55B	€ 14.06B	€ 2.07B
Total Assets	€ 21.98B	€ 22.53B	€ 23.01B	€ 23.28B	€ 15.83B
Total Debt	€ 267.29M	€ 254.20M	€ 219.10M	€ 212.20M	€ 301.50M
Net Debt	€ -7.40B	€ -9.51B	€ -11.44B	€ -13.66B	€ -1.39B
Total Liabilities	€ 2.76B	€ 3.12B	€ 2.76B	€ 3.22B	€ 3.94B
Stockholders' Equity	€ 19.22B	€ 19.41B	€ 20.25B	€ 20.06B	€ 11.89B
Cash Flow
Free Cash Flow	€ 269.81M	€ -244.60M	€ 4.67B	€ 13.21B	€ 735.70M
Operating Cash Flow	€ 438.00M	€ 207.70M	€ 5.37B	€ 13.58B	€ 889.70M
Investing Cash Flow	€ -2.37B	€ -2.08B	€ -6.95B	€ -35.30M	€ -566.10M
Financing Cash Flow	€ -50.81M	€ -45.90M	€ -778.60M	€ -1.42B	€ 94.20M

Currency in EUR

BioNTech SE Earnings and Revenue History

Income Statement >

BioNTech SE Debt to Assets

Balance Sheet >

BioNTech SE Cash Flow

Cash Flow >

BioNTech SE Forecast EPS vs Actual EPS

Earnings >